AMPE - Healthcare tops premarket gainers list
CNS Pharmaceuticals (CNSP) +62%.Cyclo Therapeutics (CYTH) +47%.Mereo BioPharma Group (MREO) +38% on licensing pact with Ultragenyx.DermTech (DMTK) +23% after announcing topline results from its TRUST Study of the company’s non-invasive melanoma rule-out test, the Pigmented Lesion Assay.180 Life Sciences (ATNF) +22%.BioTelemetry (BEAT) +18% as Philips to acquire the company for $2.8B.Sonoma Pharmaceuticals (SNOA) +18% on partnership with Gabriel Science.ALJ Regional Holdings (ALJJ) +16% on Q4 results.Acer Therapeutics (ACER) +16%.Jupiter Wellness (JUPW) +15%.Surface Oncology (SURF) +14%.PainReform (PRFX) +14%.Future FinTech Group (FTFT) +15% after company inks agreement to acquire Asiasens Investment Holding Pte. Ltd.Medicenna Therapeutics (MDNA) +14%.Ampio Pharmaceuticals (AMPE) +12%.Elys Game Technology (ELYS) +10%.MannKind Corporation (MNKD) +7% as company to co-promote Thyquidity.AIM ImmunoTech (AIM) +7%.Amyris (AMRS) +7%.Aqua Metals (AQMS) +7%.Golden Ocean Group (GOGL) +5%.Winnebago Industries (WGO) +6% on Q1 results.Uxin Limited (UXIN) +5%.Ambev S.A. (ABEV) +6%.
For further details see:
Healthcare tops premarket gainers list